Clinical Trial Update: Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effectiveness and side effects of Pegylated Interferon Alpha-2a (Pegaferon) plus Ribavirin in chronic hepatitis C patients. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegaferonae (Pegylated Interferon Alpha-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Tehran Hepatitis Center | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED